Company Arch Biopartners Inc. Toronto S.E.
Equities
ARCH
CA03938C1041
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 CAD | -1.18% | -0.59% | +13.51% |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Technologies
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +105.63% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +105.63% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Muruve
FOU | Founder | - | 83-03-03 |
Richard Muruve
FOU | Founder | - | 83-03-03 |
Andrew Bishop
DFI | Director of Finance/CFO | 58 | 10-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Rossman
BRD | Director/Board Member | - | 10-05-06 |
Richard Muruve
FOU | Founder | - | 83-03-03 |
Claude Allary
BRD | Director/Board Member | 69 | 14-03-31 |
Andrew Bishop
DFI | Director of Finance/CFO | 58 | 10-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 63,350,633 | 51,054,037 ( 80.59 %) | 0 | 80.59 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+44.76% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- ACHFF Stock
- ARCH Stock
- Company Arch Biopartners Inc.